NCT01395940View on ClinicalTrials.gov

A Randomized Open Label Study of KLH-2109 in Patients With Endometriosis(1)

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

Not specified

Conditions
Endometriosis
Interventions
DRUG

KLH-2109

DRUG

KLH-2109

Trial Locations (1)

Unknown

Japan, Tokyo and Other Japanese City

Sponsors
All Listed Sponsors
lead

Kissei Pharmaceutical Co., Ltd.

INDUSTRY